Kong Bo, Luyendyk James P, Tawfik Ossama, Guo Grace L
Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center. 3901 Rainbow Blvd., Kansas City, KS 66160, USA.
J Pharmacol Exp Ther. 2009 Jan;328(1):116-22. doi: 10.1124/jpet.108.144600. Epub 2008 Oct 23.
Nonalcoholic steatohepatitis (NASH) comprises dysregulation of lipid metabolism and inflammation. Identification of the various genetic and environmental susceptibility factors for NASH may provide novel treatments to limit inflammation and fibrosis in patients. This study utilized a mouse model of hypercholesterolemia, low-density lipoprotein receptor knockout (LDLr(-/-)) mice fed a high-fat diet for 5 months, to test the hypothesis that farnesoid X receptor (FXR) deficiency contributed to NASH development. Either the high-fat diet or FXR deficiency increased serum alanine aminotransferase activity, whereas only FXR deficiency increased bile acid and alkaline phosphatase levels. FXR deficiency and high-fat feeding increased serum cholesterol and triglycerides. Although high fat led to macrosteatosis and hepatocyte ballooning in livers of mice regardless of genotype, no inflammatory infiltrate was observed in the livers of LDLr(-/-) mice. In contrast, in the livers of LDLr(-/-)/FXR(-/-) mice, foci of inflammatory cells were observed occasionally when fed the control diet and were greatly increased when fed the high-fat diet. Consistent with enhanced inflammatory cells, hepatic levels of tumor necrosis factor alpha and intercellular adhesion molecule-1 mRNA were increased by the high-fat diet in LDLr(-/-)/FXR(-/-) mice. In agreement with elevated levels of procollagen 1 alpha 1 and TGF-beta mRNA, type 1 collagen protein levels were increased in livers of LDLr(-/-)/FXR(-/-) mice fed a high-fat diet. In conclusion, FXR deficiency induces pathologic manifestations required for NASH diagnosis in a mouse model of hypercholesterolemia, including macrosteatosis, hepatocyte ballooning, and inflammation, which suggest a combination of FXR deficiency and high-fat diet is a risk factor for NASH development, and activation of FXR may be a therapeutic intervention in the treatment of NASH.
非酒精性脂肪性肝炎(NASH)包括脂质代谢失调和炎症。识别NASH的各种遗传和环境易感性因素可能会为限制患者炎症和纤维化提供新的治疗方法。本研究利用高胆固醇血症小鼠模型,即低密度脂蛋白受体敲除(LDLr(-/-))小鼠,喂食高脂饮食5个月,以检验法尼醇X受体(FXR)缺乏导致NASH发展的假设。高脂饮食或FXR缺乏均会增加血清丙氨酸氨基转移酶活性,而只有FXR缺乏会增加胆汁酸和碱性磷酸酶水平。FXR缺乏和高脂喂养会增加血清胆固醇和甘油三酯。尽管高脂饮食会导致无论基因型如何的小鼠肝脏出现大泡性脂肪变性和肝细胞气球样变,但在LDLr(-/-)小鼠肝脏中未观察到炎症浸润。相反,在LDLr(-/-)/FXR(-/-)小鼠肝脏中,喂食对照饮食时偶尔会观察到炎症细胞灶,喂食高脂饮食时则会显著增加。与炎症细胞增多一致,高脂饮食使LDLr(-/-)/FXR(-/-)小鼠肝脏中肿瘤坏死因子α和细胞间黏附分子-1 mRNA水平升高。与I型前胶原α1和转化生长因子-β mRNA水平升高一致,喂食高脂饮食的LDLr(-/-)/FXR(-/-)小鼠肝脏中I型胶原蛋白水平升高。总之,在高胆固醇血症小鼠模型中,FXR缺乏会诱发NASH诊断所需的病理表现,包括大泡性脂肪变性、肝细胞气球样变和炎症,这表明FXR缺乏与高脂饮食相结合是NASH发展的危险因素,激活FXR可能是治疗NASH的一种治疗干预措施。